NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding NextCure, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 38 | 30 | −8 |
| Shares | 15.4M | 10.5M | −4.82M (−31.4%) |
| Value | $7.38M | $5.65M | −$1.73M (−23.5%) |
New holders (2)
Institutions that held NextCure, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 29,503 | $13.6K | 0.00% |
| Simplex Trading, LLC | 920 | $0 | 0.00% |
Sold out (10)
Institutions that held NextCure, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| OrbiMed Advisors LLC | 1,141,200 | $548.1K |
| Tang Capital Management LLC | 404,144 | $194.1K |
| Federated Hermes, Inc. | 315,180 | $151.3K |
| BML Capital Management, LLC | 273,536 | $131.4K |
| Peapod Lane Capital LLC | 265,442 | $127.5K |
| Bridgeway Capital Management, LLC | 51,700 | $24.8K |
| Engineers Gate Manager LP | 20,198 | $9.70K |
| XTX Topco Ltd | 18,028 | $8.66K |
| Millennium Management LLC | 12,272 | $5.89K |
| Dimensional Fund Advisors LP | 12,175 | $5.85K |